Microlax

Sodium citrate, sodium lauryl sulfoacetate and sorbitol, the active ingredients in Microlax, are a combination laxative presented as a rectal enema solution for rectal use. It creates an osmotic gradient and stimulates peristalsis, providing rapid relief of constipation, occasional bowel irregularities and fecal impaction in adults and children.

GNH USA supplies Microlax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures product quality through stringent quality control and provides reliable logistics for global distribution.

Microlax is an osmotic laxative used to treat conditions affecting bowel motility and stool passage.

- Constipation: facilitates rapid evacuation of hard stools and relieves abdominal discomfort. - Occasional bowel irregularities: normalizes irregular bowel movements by softening stool and stimulating peristalsis. - Fecal impaction: helps break down impacted stool and promotes clearance from the rectum.

Microlax may cause several adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping: mild discomfort in the lower abdomen. - Rectal irritation: burning or stinging sensation at the site of administration. - Diarrhea: loose stools occurring shortly after use. - Nausea: feeling of sickness without vomiting. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Severe rectal bleeding: unexpected bleeding from the rectum. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Electrolyte imbalance: abnormal sodium or citrate levels with excessive use.

Before using Microlax, consider the following precautions to ensure safe and effective use.

- Contraindication: avoid if there is rectal hemorrhage, severe inflammatory bowel disease, or recent rectal surgery. - Allergy: do not use if you are hypersensitive to sorbitol, sodium citrate, or sodium lauryl sulfoacetate. - Frequency: limit use to occasional relief; prolonged daily use may lead to dependence. - Pediatric use: consult a healthcare professional before administering to children under 3 years. - Pregnancy and lactation: discuss with a physician as safety data are limited. - Store at ambient temperature: keep the product below 25 °C, in the original container, protected from moisture and direct sunlight.

Microlax can interact with certain medications or conditions; be aware of the following.

Major Interactions (Avoid): - Antidiarrheal agents: concurrent use may reduce the efficacy of Microlax. - Oral electrolyte supplements: may alter the osmotic balance and affect stool consistency.

Moderate Interactions (Monitor Closely): - Laxatives containing magnesium: combined effect may cause excessive fluid loss. - Medications affecting intestinal motility (e.g., opioids): may require dosage adjustment. - Chronic kidney disease: monitor electrolyte status when using osmotic agents.